Source: Biomedicines. Unidade: FMRP
Subjects: FIBROSE PULMONAR, SEPSE, CICLO CELULAR, BIOMEDICINA, COLÁGENO, CITOCINAS, ENZIMAS, COVID-19
ABNT
MARGARIA, Jean Piero et al. PI3K signaling in mechanisms and treatments of pulmonary fibrosis following sepsis and acute lung injury. Biomedicines, v. 10, n. 4, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3390/biomedicines10040756. Acesso em: 01 nov. 2024.APA
Margaria, J. P., Moretta, L., Alves Filho, J. C. F., & Hirsch, E. (2022). PI3K signaling in mechanisms and treatments of pulmonary fibrosis following sepsis and acute lung injury. Biomedicines, 10( 4), 1-10. doi:10.3390/biomedicines10040756NLM
Margaria JP, Moretta L, Alves Filho JCF, Hirsch E. PI3K signaling in mechanisms and treatments of pulmonary fibrosis following sepsis and acute lung injury [Internet]. Biomedicines. 2022 ; 10( 4): 1-10.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/biomedicines10040756Vancouver
Margaria JP, Moretta L, Alves Filho JCF, Hirsch E. PI3K signaling in mechanisms and treatments of pulmonary fibrosis following sepsis and acute lung injury [Internet]. Biomedicines. 2022 ; 10( 4): 1-10.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/biomedicines10040756